Sunflower Pharmaceutical Co., Ltd. logo

Sunflower Pharmaceutical Co., Ltd. (002737)

Market Open
11 Aug, 06:57
XSHE XSHE
¥
13. 61
+0.11
+0.8148%
¥
8.8B Market Cap
- P/E Ratio
2% Div Yield
749,400 Volume
- Eps
¥ 13.5
Previous Close
Add Transaction
Day Range
13.49 13.64
Year Range
11.04 16.42
Want to track 002737 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002737 trading today higher at ¥13.61, an increase of 0.8148% from yesterday's close, completing a monthly increase of 21.0854% or ¥2.37. Over the past 12 months, 002737 stock lost -7.8538%.
002737 pays dividends to its shareholders, with the most recent payment made on Jul 17, 2026. The next estimated payment will be in In 11 months on Jul 17, 2027 for a total of ¥0.2.
The last earnings report, released on May 30, 2025, exceeded the consensus estimates by 0.0978%. On average, the company has surpassed earnings expectations by 0.2219%, based on the last three reports.
Sunflower Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Apr 18, 2018.
The company's stock is traded on one exchange.

002737 Chart

People also search for

Dr Corp Ltd.
¥ 23.68
-1.0447%
Sunvim Group Co., Ltd.
¥ 11.97
-1.2376%
Tibet Gaozheng Explosive Co., Ltd.
¥ 59
-0.9735%
Innovative Medical Management Co., Ltd.
¥ 21.68
-1.0949%
Henan Liliang Diamond Co., Ltd.
¥ 58.62
-2.3488%

Sunflower Pharmaceutical Co., Ltd. (002737) FAQ

What is the stock price today?

The current price is ¥13.61.

On which exchange is it traded?

Sunflower Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002737.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2%.

What is its market cap?

As of today, the market cap is 8.8B.

Has Sunflower Pharmaceutical Co., Ltd. ever had a stock split?

Sunflower Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Apr 18, 2018.

Sunflower Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Yi Guan CEO
XSHE Exchange
CNE100001WT7 ISIN
CN Country
5,727 Employees
17 Jul 2026 Last Dividend
18 Apr 2018 Last Split
- IPO Date

Overview

Sunflower Pharmaceutical Group Co.,Ltd, established in 2005 and headquartered in Harbin, China, specializes in the arena of pharmaceuticals with a focus on the development, manufacturing, and marketing of Chinese patent medicines both domestically and on a global scale. The company has diversified its portfolio to include the production of chemical and biological medicines along with health care products, catering to the wide-ranging needs of its customer base. Its international presence is marked by its commitment to providing top-tier medicines and healthcare products across various segments.

Products and Services

Sunflower Pharmaceutical Group Co.,Ltd offers a broad array of products and services across different therapeutic areas and healthcare needs, such as:

  • Pediatrics: Catering to the healthcare needs of children, the company offers specialized medicinal products designed to address a wide variety of pediatric conditions, ensuring safe and effective treatment options for the younger population.
  • Gynecology: With a focus on women’s health, Sunflower Pharmaceutical provides a range of products intended for the treatment and management of gynecological conditions, affirming its commitment to addressing the unique healthcare requirements of women.
  • Digestive System: Offering solutions for digestive health issues, the company provides medications aimed at improving digestive system function and treating conditions affecting the gastrointestinal tract.
  • Respiratory and Cold: For individuals suffering from respiratory ailments and common cold symptoms, Sunflower Pharmaceutical offers a variety of treatments designed to alleviate symptoms and support the respiratory system’s health.
  • Rheumatic Bone Disease: Specializing in the treatment of rheumatic conditions and bone diseases, the company’s products aim to relieve pain, reduce inflammation, and improve overall joint and bone health.
  • Cardiovascular and Cerebrovascular: Focusing on the heart and blood vessels, the company’s cardiovascular and cerebrovascular products offer treatments for disorders affecting these critical systems, contributing to better heart health and stroke prevention.
  • Supplements: Beyond treatments for specific conditions, Sunflower Pharmaceutical provides a range of health supplements designed to support overall well-being and prevent nutrient deficiencies.
  • Antibiotics: The company’s antibiotic offerings are focused on combating bacterial infections, providing effective treatments to prevent and halt the spread of bacterial diseases.
  • Children's Medicinal Products: Under the Little Sunflower brand, the company offers medications specifically formulated for children, ensuring the safety and effectiveness of treatments tailored to the pediatric population.

These products are marketed under the Sunflower and Little Sunflower brands, reflecting the company’s dedication to quality and customer trust in its extensive range of healthcare solutions.

Contact Information

Address: Concentrated Area, Yingbin Road, Harbin, China, 150078
Phone: 86 451 8236 7108